Description

ANDROLIC (Oxymetholone) 50 mg

Brand: The British Dispensary Co. LTD
Category: Oral AAS Research Compound
Content: 100 tablets | 50 mg per tablet
Price: €59
Manufactured in: Thailand

🧪 Product Overview

Oxymetholone 50 mg, commercially known as ANDROLIC, is a structurally modified
17-α-alkylated dihydrotestosterone (DHT) derivative developed for hematologic and androgen-receptor (AR)
modulation research. Its strong anabolic index, erythropoietic activity, and well-documented hepatic risk profile
make it a key reference standard in studies of AR signaling, EPO regulation, and steroid toxicology.

Originally used clinically for anemia, oxymetholone has shown notable increases in erythropoietin (EPO),
red-cell mass, and protein-synthesis pathways. Its 17-α-alkylated structure enhances oral bioavailability
while elevating hepatotoxicity risk, supporting reproducible liver-injury modeling.

✅ Key Research Highlights

Enhanced erythropoiesis:
FDA and NCBI data confirm increased erythropoietin and hematologic output.

Potent AR agonism:
Strong anabolic transcriptional signaling suitable for AR-targeted assays.

High oral stability with hepatic strain:
17-α-alkylation increases bioavailability but introduces significant hepatotoxicity.

Endocrine & metabolic effects:
Dyslipidemia, suppression of endogenous hormones, fluid retention, and virilization endpoints.

🧬 Suggested Laboratory Applications

• Hematologic stimulation modeling (EPO & red-cell regulation)
• Androgen receptor activation & gene-transcription studies
• Anabolic-androgenic steroid toxicology
• Hepatic injury modeling (peliosis, cholestasis, tumor pathways)
• Comparative anabolic potency benchmarks

📊 Technical Specifications

❄️ PubChem-Supported Research Insights

• Strong AR agonist with high transcriptional activity
• Enhances erythropoietin through androgen-mediated signaling
• Marked hepatic strain due to 17-α-alkylation
• Valuable as a toxicology reference in steroid metabolism studies
• Affects lipid regulation and endocrine pathways

⚠️ Documented Research Side Effects

• Hepatic tumors, peliosis hepatis, cholestatic jaundice (FDA warnings)
• Dyslipidemia (↑ LDL / ↓ HDL)
• Edema and altered fluid retention
• Suppression of endogenous testosterone
• Virilization endpoints in androgen-sensitive models

🧯 Handling & Compliance

For Research Use Only — Not for human or veterinary application.
Store dry, protected from light, below 30 °C.
Listed under WADA S1 prohibited anabolic agents.
Purchase confirms qualified researcher status.